BOSTON SCIENTIFIC CORPORATION Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized
BOSTON SCIENTIFIC CORPORATION (BSX) reported Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized of 10.00 million shares for the 12-month period ending 2024-12-31, per its 10-K filed 2025-02-18.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized · last filed 2025-02-18
- BOSTON SCIENTIFIC CORPORATION share-based compensation arrangement by share-based payment award, number of additional shares authorized for fiscal 2024 was 10.00M shares, a 0.00% change from fiscal 2023.
- BOSTON SCIENTIFIC CORPORATION share-based compensation arrangement by share-based payment award, number of additional shares authorized for fiscal 2023 was 10.00M shares, a 0.00% change from fiscal 2022.
- BOSTON SCIENTIFIC CORPORATION share-based compensation arrangement by share-based payment award, number of additional shares authorized for fiscal 2022 was 10.00M shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized 12 month |
|---|---|
| 2024-12-31 | 10.00M shares 10-K · filed 2025-02-18 |
| 2023-12-31 | 10.00M shares 10-K · filed 2024-02-20 |
| 2022-12-31 | 10.00M shares 10-K · filed 2023-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| STRYKER CORP (SYK) | United States | $103.511B | 32.39 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |